Aktienanalyse zu Henry Schein Inc (HSIC)HSICHenry Schein Inc

Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products. It operates in the Healthcare sector (WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & S industry).

Henry Schein Inc appears to be a good buy right now, with a current price of $84.01 and a forward P/E of 14.81, indicating potential undervaluation compared to its earnings growth prospects. The company reported a 6.7% revenue increase in Q2 2026, reaching $3.458 billion, and has a solid EPS guidance of $5.29 to $5.39 for the full year, reflecting strong confidence in future performance. However, the RSI is at 40.78, suggesting it is nearing oversold territory, which could indicate a buying opportunity. The main risk is the recent 5-day change of -1.02%, which shows a slight downward trend in the short term, but overall fundamentals and analyst sentiment remain strong.

16 analysts cover HSIC: 9 rate it Buy, 7 Hold and 0 Sell. The average price target is 76.78.